# CORONA — CORONA Remedies Limited

> CORONA Remedies Limited (CORONA) on the NSE: 170 sessions of split-adjusted history from 2025.

Canonical: https://patternsradar.com/s/CORONA

## Latest session

- Close: 2,142.6 INR (-1.07% on the day), 2026-08-21
- Delivery: 53.1% of volume taken to demat (20-day average 52.29%)
- Volume: 12.6K shares, turnover ₹2.7Cr
- Relative volume: 0.28× of its own 20-day average

## Technicals

- RSI(14): 58.51
- ATR(14): 67.29
- SMA 50: 2,021.29, SMA 200: —
- 52-week range: — – — (— from the high)

## Performance

- 1 week 0.26%, 1 month 5.56%, 3 months 27.19%
- 6 months 38.84%, 1 year —

## Fundamentals

- Market cap: 13,104.2 crore
- P/E (TTM): 65.84 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 32.54 INR, split-adjusted to match the price series
- Revenue growth: — YoY, 19.64% QoQ
- Profit growth: — YoY, 32.61% QoQ

## Quarterly results

Last 4 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2025-09-30 | 361.1 | 293.8 | 69.6 | 52.3 | 8.55 | 14.49% |
| 2025-12-31 | 342.4 | 270.4 | 55.2 | 41.3 | 6.75 | 12.05% |
| 2026-03-31 | 353.1 | 302.7 | 54.7 | 45.3 | 7.41 | 12.84% |
| 2026-06-30 | 422.4 | 345.2 | 80.4 | 60.1 | 9.83 | 14.23% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 69%
- Public: 31%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-07-31: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_181245_31072026180520_iXBRL_WEB.html
- 2026-07-13: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1691245_13072026010858_WEB.xml
- 2026-06-19: dividend
- 2026-05-11: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_156718_11052026193243_iXBRL_WEB.html
- 2026-04-17: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1653023_17042026022348_WEB.xml
- 2026-02-02: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139732_02022026192314_iXBRL_WEB.html
- 2026-01-20: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1605817_20012026051423_WEB.xml
- 2026-01-05: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_133716_05012026124551_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 9 events are indexed for this instrument.

## About the instrument

- Listed: 2025-12-15 — latest session 2026-08-21 (170 sessions)
- ISIN: INE02ZQ01018
- Series: EQ
- Liquidity rank: #1034 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/CORONA.